Description: This volume in a series on emerging and reemerging infectious diseases focuses on the latest clinical and public health issues surrounding sexually-transmitted genital infections caused by Chlamydia trachomatis in humans.
Purpose: The editor gathers internationally recognized experts to provide the latest information and to fill a gap in the literature on both the clinical and public health aspects of this sexually-transmitted infection. The book does not attempt to cover chlamydial diseases of the eye or lung, nor diseases caused by other chlamydial species, which are well covered elsewhere.
Audience: While explicitly aimed at medical scientists and clinical practitioners, the book also would benefit those involved in the massive public health efforts to address this complex problem, from public health policy makers to disease surveillance practitioners.
Features: The book is part comprehensive review and part primer on emerging issues and affected populations. Although it contains relatively few illustrations, the book provides thorough coverage of topics including current epidemiology, prevention, and control; pathogenicity, diagnosis, and treatment; and immunology and vaccine development. Other chapters focus on maternal and infant infections, infection among sexual minorities, and lymphogranuloma venereum (LGV), an uncommon but increasingly important disease among men who have sex with men.
Assessment: This is a good, up-to-date, clinical and public health reference for clinicians and scientists involved in the care, diagnosis, and treatment of patients with chlamydial infection. Additionally, and perhaps more importantly, it provides a good perspective for public health practitioners and policy makers about interpreting surveillance data in a setting where case reports may increase due to increased screening efforts and improvements in testing sensitivity.